Scott Fidel
Stock Analyst at Stephens & Co.
(2.00)
# 3,112
Out of 5,139 analysts
185
Total ratings
50%
Success rate
-6.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GRDN Guardian Pharmacy Services | Maintains: Overweight | $35 → $36 | $27.03 | +33.19% | 2 | Jan 14, 2026 | |
| ARDT Ardent Health | Maintains: Overweight | $21 → $17 | $8.60 | +97.67% | 7 | Nov 14, 2025 | |
| CI The Cigna Group | Maintains: Buy | $370 → $330 | $272.21 | +21.23% | 14 | Nov 4, 2025 | |
| CNC Centene | Maintains: Sell | $33 → $38 | $45.75 | -16.94% | 12 | Oct 31, 2025 | |
| HCA HCA Healthcare | Maintains: Buy | $470 → $520 | $469.29 | +10.81% | 11 | Oct 27, 2025 | |
| MOH Molina Healthcare | Maintains: Neutral | $207 → $167 | $191.40 | -12.75% | 11 | Oct 24, 2025 | |
| UHS Universal Health Services | Assumes: Neutral | $219 | $199.88 | +9.57% | 11 | Oct 14, 2025 | |
| THC Tenet Healthcare | Assumes: Buy | $224 | $196.74 | +13.86% | 11 | Oct 14, 2025 | |
| OSCR Oscar Health | Initiates: Neutral | $17 | $16.55 | +2.72% | 1 | Oct 14, 2025 | |
| ELV Elevance Health | Initiates: Neutral | $343 | $374.87 | -8.50% | 4 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $22.50 | -6.67% | 6 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $91 | $78.60 | +15.78% | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $406 | $331.02 | +22.65% | 23 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $38 | $29.18 | +30.23% | 18 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $48 → $31 | $38.77 | -20.04% | 4 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $143 → $145 | $107.51 | +34.88% | 11 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $163 → $167 | $180.57 | -7.52% | 9 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $250 | $273.28 | -8.52% | 7 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $100.50 | +4.48% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $11.68 | +687.67% | 9 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $9.22 | -83.73% | 3 | Nov 11, 2022 |
Guardian Pharmacy Services
Jan 14, 2026
Maintains: Overweight
Price Target: $35 → $36
Current: $27.03
Upside: +33.19%
Ardent Health
Nov 14, 2025
Maintains: Overweight
Price Target: $21 → $17
Current: $8.60
Upside: +97.67%
The Cigna Group
Nov 4, 2025
Maintains: Buy
Price Target: $370 → $330
Current: $272.21
Upside: +21.23%
Centene
Oct 31, 2025
Maintains: Sell
Price Target: $33 → $38
Current: $45.75
Upside: -16.94%
HCA Healthcare
Oct 27, 2025
Maintains: Buy
Price Target: $470 → $520
Current: $469.29
Upside: +10.81%
Molina Healthcare
Oct 24, 2025
Maintains: Neutral
Price Target: $207 → $167
Current: $191.40
Upside: -12.75%
Universal Health Services
Oct 14, 2025
Assumes: Neutral
Price Target: $219
Current: $199.88
Upside: +9.57%
Tenet Healthcare
Oct 14, 2025
Assumes: Buy
Price Target: $224
Current: $196.74
Upside: +13.86%
Oscar Health
Oct 14, 2025
Initiates: Neutral
Price Target: $17
Current: $16.55
Upside: +2.72%
Elevance Health
Oct 14, 2025
Initiates: Neutral
Price Target: $343
Current: $374.87
Upside: -8.50%
Oct 14, 2025
Initiates: Buy
Price Target: $21
Current: $22.50
Upside: -6.67%
Oct 14, 2025
Initiates: Buy
Price Target: $91
Current: $78.60
Upside: +15.78%
Oct 14, 2025
Initiates: Buy
Price Target: $406
Current: $331.02
Upside: +22.65%
Mar 11, 2025
Reiterates: Overweight
Price Target: $38
Current: $29.18
Upside: +30.23%
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $38.77
Upside: -20.04%
Nov 6, 2024
Maintains: Overweight
Price Target: $143 → $145
Current: $107.51
Upside: +34.88%
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $180.57
Upside: -7.52%
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $273.28
Upside: -8.52%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $100.50
Upside: +4.48%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $11.68
Upside: +687.67%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $9.22
Upside: -83.73%